A gavel on cash next to pills spilled from a bottle — First Opinion coverage from STAT
Adobe

By Rachel Cohrs Zhang

Sept. 20, 2024

Chief Washington Correspondent

WASHINGTON — A federal appeals court ruled that three organizations, including the brand drug lobby PhRMA, can challenge Medicare’s drug price negotiation program in a lower court based in Texas.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe
, , , , , , ,
Submit a correction requestReprints

  1. Rachel Cohrs Zhang

    Chief Washington Correspondent

    Rachel Cohrs Zhang reports on the intersection of health policy and business in Washington. She covers Capitol Hill, lobbying, and federal agencies. Her primary areas of focus are the pharmaceutical and hospital industries. She is also the co-author of the free, twice-weekly D.C. Diagnosis newsletter.